Pascal Benkert
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 139 publications
A community-validated tool for clinical outcome calculation in multiple sclerosis: Consensus development and scenario-specific recommendations.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 22, 2026
Anti-CD20 B cell depletion is associated with elevated mucosal-originating circulating regulatory IgA B cells in multiple sclerosis.
Journal: Science translational medicine
Published: July 22, 2026
Exploring serum biomarkers in paediatric psychiatry: the impact of NfL and GFAP.
Journal: Translational psychiatry
Published: July 14, 2026
Serum Glial Fibrillary Acidic Protein and Retinal Neuronal Loss as Additive Prognostic Markers of Disability in Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: May 13, 2026
Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: April 23, 2026
From measurement to biomarker trajectories: platform-agnostic Z score analysis of serum NfL and GFAP in ocrelizumab-treated multiple sclerosis.
Journal: Journal of neurology
Published: March 23, 2026
Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Potential Early Indicators of Osmotic Brain Stress in Hyponatremia and Its Correction.
Journal: European journal of endocrinology
Published: March 01, 2026
Neurofilament light chain and glial fibrillary acidic protein as potential early indicators of osmotic brain stress in hyponatremia and its correction.
Journal: European journal of endocrinology
Published: March 01, 2026
Diagnostic and prognostic value of blood neurofilament light chain in ischemic stroke: an individual patient data meta-analysis.
Journal: Journal of neurology
Published: February 27, 2026
Last Updated: 09/26/2026